From: Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
Reporter ID1 | Gene symbol2 | Cytoband | Description2 | Ratio3 | Function4 |
---|---|---|---|---|---|
Upregulated in node positive tumors | |||||
32134 | DNAJC9 | 10q22.2 | DnaJ (Hsp(40) homolog, subfamily C, member 9 | 1.35 | Protein folding |
824723 | MRPS23 | 17q22 | Mitochondrial ribosomal protein S23 | 1.33 | Structural component of mitochondrial ribosome |
144880 | PLAC2 | 19p13.3 | Placenta-specific 2 | 1.47 | Unknown |
840486 | VWF | 12p13.3 | Von Willebrand factor | 1.35 | Coagulation |
345957 | CSTA | 3q21 | Cystatin A | 2.24 | Lysosomal proteinase inhibition |
49860 | PDK2 | 17q21.33 | Pyruvate dehydrogenase kinase, isoenzyme 2 | 1.23 | Anaerobe metabolism |
359119 | CKS2 | 9q22 | CDC28 protein kinase regulatory subunit 2 | 1.25 | Cell cycle regulation |
321354 | In multiple clusters | 1.27 | |||
825012 | MGC14151 | 17p13.1 | Hypothetical protein MGC14151 | 1.29 | |
796176 | LSM3 | 3p25.1 | Hypothetical protein LOC285378 | 1.31 | MRNA splicing |
825229 | MRPL11 | 11q13.3 | Mitochondrial ribosomal protein L11 | 1.24 | Structural component of mitochondrial ribosome |
50671 | FLJ12716 | 4q35.1 | FLJ12716 protein | 1.24 | |
50491 | BAI3 | 6q12 | Brain-specific angiogenesis inhibitor 3 | 1.37 | Angiogenesis |
129516 | RCL1 | 9p24.1 | RNA terminal phosphate cyclase-like 1 | 1.21 | Maturation of 18S RNA |
290607 | NEK1 | 4q33 | NIMA (never in mitosis gene a) – related kinase 1 | 1.32 | DNA damage repair |
128208 | DKFZp586I1420 | 7p15.1 | Hypothetical protein DKFZp586I1420 | 1.21 | |
Downregulated in node positive tumors | |||||
210698 | EPB41L4B | 9q31 | Erythrocyte membrane protein band 4.1 like 4B | 0.71 | Structural constituent of cytoskeleton |
810391 | HYAL1 | 3p21.3 | Hyaluronglucosaminidase 1 | 0.62 | Degradation of extracellular matrix components |
1637282 | HK2 | 2p13 | Hexokinase 2 | 0.70 | Glucose metabolism |
320392 | MBNL2 | 13q32.1 | Muscleblind-like 2 (Drosophila) | 0.70 | MRNA splicing |
767769 | FLJ13291 | 16q22.1 | Hypothetical protein FLJ13291 | 0.82 | |
126519 | KLF3 | 4p14 | Krüppel-like factor 3 (basic) | 0.83 | Glucose metabolism, growth, apoptosis, angiogenesis |
230100 | In multiple clusters | 0.76 | |||
347546 | ERO1L | 14q22.1 | ERO1-like (S. cerevisiae) | 0.76 | Oxidative protein folding |
131362 | MSN | Xq11.2 | Moesin | 0.71 | Cell-cell and -extracellular matrix interaction |
137456 | TBX3 | 12q24.1 | T-box 3 (ulnar mammary syndrome) | 0.74 | Regulation of growth and developmental processes |
755506 | ANXA4 | 2p13 | Annexin A4 | 0.72 | Growth regulation, apoptosis, calcium signaling |
284619 | In multiple clusters | 0.81 | |||
143661 | NTN4 | 12q22 | Netrin 4 | 0.71 | Cell-cell and -extracellular matrix interaction |
713469 | MEF2A | 15q26 | Myocyte enhancer factor 2A | 0.79 | Growth factor related transcription, differentiation |
251135 | DDOST | 1p36.1 | Dolichyl-diphosphooligosaccharide-protein glycosyltransferase | 0.72 | Glycosylation, apoptosis |